COOPERALA - Cámara Empresaria de Laboratorios Farmacéuticos

What COOPERALA - Cámara Empresaria de Laboratorios Farmacéuticos does

COOPERALA (Cámara Empresaria de Laboratorios Farmacéuticos) is an Argentine business chamber representing the largest aggregation of pharmaceutical laboratories operating in Argentina, with a membership roster exceeding 70 national and international laboratories including Bagó, Teva, Glenmark, Aspen, Knight Therapeutics, SIDUS, and others. Founded in 1959 as a cooperative and reorganized in 1998 as a business chamber while preserving one-member-one-vote governance, COOPERALA operates nine standing working commissions covering labor (FATSA, APM), health insurers (PAMI, Obras Sociales Provinciales, prepagas), tax, environment, oncology and special treatments, dietary supplements, foreign trade, and science and technology (DECyTEP). Its core products and services are not commercial goods but institutional services: collective negotiation with payers and unions, regulatory advocacy with ANMAT/INAME and the Ministry of Health, technical training programs (including GMP, quality indicators, and a newly introduced Generative AI curriculum), dissemination of regulatory updates, and participation in Mercosur SGT N° 11 and PAHO/OPS policy forums.

The chamber's technology surface is thin and oriented toward member enablement rather than proprietary product development: it delivers virtual training via Zoom, distributes regulatory and market intelligence through email and a website (cooperala.org.ar), and uses WhatsApp for member notifications. There is no disclosed SaaS platform, API, mobile application, or proprietary AI model. DECyTEP, established in 1990 with the SECyT and the University of Buenos Aires' Faculty of Pharmacy and Biochemistry, constitutes the chamber's most enduring technical asset, providing scientific-technical linkage and curriculum design for member laboratory personnel.

COOPERALA's business model is membership-funded; no public pricing for membership dues or services is disclosed, and all training courses are offered free of charge to members. Revenue, headcount, and financial statements are not publicly available. The chamber does not pursue equity funding, has no parent company, and is governed by a Board of Directors drawn from member laboratories under cooperative-style equal representation. Its GTM is relationship-driven and institutional rather than commercial sales, with member acquisition and retention anchored in regulatory representation, payer negotiation outcomes, and the practical value of its working commissions and training programs.

Name

COOPERALA - Cámara Empresaria de Laboratorios Farmacéuticos

Legal name

Cooperativa de Laboratorios Argentinos de Especialidades Medicinales para el Abastecimiento y Distribución Limitada

Website

https://cooperala.org.ar

Company type

Private

Founded year

1959

Operating status

Operating

Headcount range

1–10 employees

Short description

COOPERALA is the Argentine business chamber representing over 70 pharmaceutical laboratories, providing collective negotiation with payers and unions, regulatory advocacy with ANMAT and the Ministry of Health, technical training, and Mercosur policy engagement for its members.

Ownership category

akta.pro rank

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels6 records

Core offering

COOPERALA is a business chamber (cámara empresaria) that represents more than 70 pharmaceutical laboratories in Argentina, founded in 1959 in Buenos Aires. It delivers collective industry representation, regulatory advocacy, collective bargaining support, technical training, and technical reports to its member laboratories through dedicated working commissions and a Scientific and Technical Department (DECyTEP).

Product overview

COOPERALA is a chamber/association of Argentine pharmaceutical laboratories (Cámara Empresaria de Laboratorios Farmacéuticos), not a product company. Its services consist of working commissions addressing industry issues (laboral, credits, tax, environment, health insurance, oncology, dietary supplements, foreign trade, and science/technology), technical training programs including AI Generative training for pharmaceutical industry functions and quality indicators courses, and the DECyTEP department providing scientific-technical linkage and regulatory compliance support for GMP, ANMAT, and INAME standards. The association facilitates collective problem-solving and professional development for member pharmaceutical laboratories across Argentina.

Differentiator

Problem solved

Functional benefit

Products and services

• Working Commissions (Comisiones de Trabajo)

Named customers80 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

• Organización Panamericana de la Salud (OPS)flagshipStrategic or Co-development PartnerCOOPERALA participated in a high-level meeting organized by the Pan American Health Organization (PAHO) and Argentina's Ministry of Health with Argentine pharmaceutical producers. The meeting highlighted Argentina's high technological capacity and qualified human capital, positioning Argentine laboratories as strategic suppliers for the entire region. COOPERALA committed to actively participating in working groups to operationalize public-private synergies, and the meeting discussed access to PAHO's Revolving Fund and Strategic Fund for procurement of pharmaceutical products across the region.
• Ministerio de Salud de la Nación ArgentinacoreStrategic or Co-development PartnerCOOPERALA collaborates with Argentina's Ministry of Health on regulatory, public health, and pharmaceutical industry policy matters. The chamber participated in the March 2026 OPS-Ministry-Sector meeting, affirming shared goals of clear regulatory rules ('seguridad jurídica') to enable private sector investment and productive capacity scaling.
• Mercosur — SGT Nº 11 SaludcoreStrategic or Co-development PartnerCOOPERALA participates in Mercosur's Subgrupo de Trabajo Nº 11 (SGT 11) on Health, engaging in discussions on regional pharmaceutical regulation and trade. This participation enables member laboratories to influence and stay informed on intra-bloc regulatory harmonization and trade policy developments.
• ANMAT / INAMEcoreStrategic or Co-development PartnerCOOPERALA maintains active engagement with ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica) and its INAME (Instituto Nacional de Medicamentos) on regulatory matters including GMP compliance, ANMAT norms, and technical training. The DECyTEP department serves as a technical interface with ANMAT/INAME updates.
• PAMI (Instituto Nacional de Servicios Sociales para Jubilados y Pensionados)coreStrategic or Co-development PartnerPAMI is Argentina's largest public health insurer for retirees and pensioners, representing a critical payer for member pharmaceutical laboratories. COOPERALA's Obras Sociales commission specifically negotiates and monitors the PAMI agreement, tracking renegotiations, capitations, and payment chain developments on behalf of its members.
• FATSA (Federación de Asociaciones de Trabajadores de la Sanidad Argentina)coreStrategic or Co-development PartnerCOOPERALA represents member laboratories in collective wage bargaining negotiations with FATSA (the union for healthcare/sanidad workers). The Labor Commission analyzes and discusses the terms of collective bargaining agreements signed with FATSA, and coordinates the position brought to wage negotiations (paritarias).
• APM (Asociación Agentes de Propaganda Médica)coreStrategic or Co-development PartnerCOOPERALA coordinates with APM (the medical sales representatives union) on collective bargaining agreements, labor negotiations, and regulatory matters affecting the pharmaceutical sales workforce. The Labor Commission tracks and analyzes agreements with APM for member laboratories.
• SECyT / CONICET / Universidad de Buenos Aires (Facultad de Farmacia y Bioquímica)minorStrategic or Co-development PartnerEstablished in 1990, this partnership aimed to create formal links between COOPERALA member laboratories and the scientific community. It led to the creation of DECyTEP, the Science and Technology Department for Production, dedicated to scientific-technological linking and technical training for laboratory personnel.
• Obras Sociales Provinciales (IOMA, Apross, Osep Mendoza, and others)coreStrategic or Co-development PartnerCOOPERALA's Obras Sociales commission manages negotiations with provincial health insurers including IOMA (Buenos Aires), Apross (Córdoba), and Osep Mendoza, among others. The commission tracks renegotiations, capitations, and coverage evolutivos, providing detailed reports to member laboratories on the status of all agreements.

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Direct peers

• CILFA (Cámara Industrial de Laboratorios Farmacéuticos Argentinos): Argentine pharmaceutical industry chamber representing mostly multinational and large national laboratories. Directly comparable to COOPERALA as a competing industry chamber in Argentina, competing for the same member base, government access (ANMAT, PAMI), and collective-bargaining role, but skewed toward larger and multinational players rather than PyMEs.
• CAEMe (Cámara Argentina de Especialidades Medicinales): Argentine chamber of medicinal specialties whose member mix overlaps heavily with COOPERALA's. Directly comparable as a chamber providing collective representation for pharma labs in Argentina on regulatory, labor, and health-insurer matters, and is the most common alternative affiliation for an Argentine pharmaceutical laboratory.

Broad incumbents

• FIFARMA (Federación Latinoamericana de la Industria Farmacéutica): Latin American pharma-industry federation aggregating national chambers across the region. Comparable to COOPERALA as an industry-association counterpart operating at a regional rather than national level, and a relevant counterpart for COOPERALA's Mercosur SGT 11 and PAHO engagement work.
• PhRMA (Pharmaceutical Research and Manufacturers of America): U.S. pharma research-and-manufacturers association. A broad-incumbent industry-association peer; not a competitor but a structural analog that demonstrates the scale and service breadth a national pharma chamber can grow into over decades of operation.
• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global pharma industry federation headquartered in Geneva. A broad-incumbent peer covering the same industry-association function at worldwide scale, setting policy positions on GMP, access, and trade that COOPERALA members interface with indirectly through FIFARMA and PAHO engagement.

Regional players

• CANIFARMA (Cámara Nacional de la Industria Farmacéutica, Mexico): Mexican pharma industry chamber covering national manufacturers. A regional industry-association peer performing the same collective-representation function for pharma labs in Mexico; useful benchmark on how chamber offerings (training, regulatory advocacy, labor bargaining) are structured in another major LATAM market.
• INTERFARMA (Associação da Indústria Farmacêutica de Pesquisa, Brazil): Brazilian research-based pharma industry association representing innovators and large national labs. A regional peer because it operates the chamber/association model in the largest LATAM pharma market; comparable in role (industry advocacy, regulatory interface, training) but not directly competitive given the Brazil geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cooperala-camara-empresaria-de-laboratorios-farmaceuticos

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COOPERALA - Cámara Empresaria de Laboratorios Farmacéuticos